Tamara Leigh Weaver, ND | |
222 Front St, Fairbanks, AK 99701-3145 | |
(907) 451-7100 | |
Not Available |
Full Name | Tamara Leigh Weaver |
---|---|
Gender | Female |
Speciality | General Practice |
Location | 222 Front St, Fairbanks, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821285990 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 66 (Alaska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Tamara Leigh Weaver, ND 222 Front St, Fairbanks, AK 99701-3145 Ph: (907) 451-7100 | Tamara Leigh Weaver, ND 222 Front St, Fairbanks, AK 99701-3145 Ph: (907) 451-7100 |
News Archive
A new study conducted in the Center for Health Policy at the University of Nebraska Medical Center College of Public Health has determined that racial and ethnic minorities are less likely to be screened for colorectal cancer in the United States.
Hospedia, the leading provider of point of care systems for healthcare, has partnered with thebigword – a global, technology driven language solutions provider - to give patients and clinicians immediate access to interpreters directly at their bedside in 160 hospitals across the UK.
Today, around the world, more than two billion world citizens do not have access to emergency and essential surgical care. The results are devastating, leading to more than 500,000 maternal deaths and more than 5 million fatalities associated with everyday injuries such as road traffic accidents and burns. This lack of surgical care is arguably a top killer around the world but mostly ignored by organizations that can affect positive change.
Siemens Canada Limited made the list as part of the 2010 winners of the Canada's Top 100 Employers competition.
S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.
› Verified 3 days ago
Dr. Nicholas Paul Cosentino, D.O General Practice Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-5358 | |
Larry Allen Harikian, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1867 Airport Way, Ste 130b, Fairbanks, AK 99701 Phone: 907-452-2178 Fax: 907-452-3524 | |
Dr. Robert Matthew Monberg, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 3788 University Ave S Ste 304, Fairbanks, AK 99709 Phone: 907-456-4825 Fax: 907-456-4899 |